An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Amneal to Participate at Upcoming Investor Conferences in May
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Amneal Pharmaceuticals (NYSE: AMRX) will participate in several investor conferences, including the RBC Healthcare Conference on May 17, 2022, and the UBS Healthcare Conference on May 25, 2022, both in New York City. Additionally, the company will feature in the Barclays CEO Call Series on May 27, 2022, at 10:00 AM Eastern Time. As a fully-integrated essential medicines company, Amneal specializes in generic and specialty pharmaceuticals with a diverse portfolio of over 250 products. For more information, visit www.amneal.com.
Positive
None.
Negative
None.
BRIDGEWATER, N.J.--(BUSINESS WIRE)--
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today announced that its investor relations or management team will attend the following investor conferences:
RBC Healthcare Conference May 17, 2022 Investor Relations Hosted Meetings
New York, New York
UBS Healthcare Conference May 25, 2022 Investor Relations Hosted Meetings
New York, New York
Barclays CEO Call Series
May 27, 2022 Fireside Chat – 10:00am Eastern Time
About Amneal
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals, primarily within the United States. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across a broad range of complex products and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceutical products focused primarily on central nervous system and endocrine disorders, with a pipeline focused on unmet needs. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more information, please visit www.amneal.com.
What dates will Amneal Pharmaceuticals attend investor conferences in May 2022?
Amneal Pharmaceuticals will attend the RBC Healthcare Conference on May 17, 2022, the UBS Healthcare Conference on May 25, 2022, and the Barclays CEO Call Series on May 27, 2022.
Where are the investor conferences for Amneal Pharmaceuticals being held?
The RBC and UBS Healthcare Conferences will be held in New York City, while the Barclays CEO Call Series will also take place virtually.
What stock symbol represents Amneal Pharmaceuticals?
Amneal Pharmaceuticals is represented by the stock symbol AMRX.
What is the focus of Amneal Pharmaceuticals' product portfolio?
Amneal Pharmaceuticals focuses on generic and specialty pharmaceuticals, with over 250 products and a growing portfolio in areas such as injectables and biosimilars.
Who can be contacted for investor relations at Amneal Pharmaceuticals?
Tony DiMeo is the Head of Investor Relations and can be contacted at Anthony.DiMeo@amneal.com.
